Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma
Clinical trial NCT02603887 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02603887
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-20
- Primary completion
- 2017-12-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.